학술논문
Reported cases of multisystem inflammatory syndrome in children aged 12–20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation
Document Type
Article
Author
Yousaf, Anna R; Cortese, Margaret M; Taylor, Allan W; Broder, Karen R; Oster, Matthew E; Wong, Joshua M; Guh, Alice Y; McCormick, David W; Kamidani, Satoshi; Schlaudecker, Elizabeth P; Edwards, Kathryn M; Creech, C Buddy; Staat, Mary A; Belay, Ermias D; Marquez, Paige; Su, John R; Salzman, Mark B; Thompson, Deborah; Campbell, Angela P; Museru, Oidda; Howard, Leigh M.; Parise, Monica; Openshaw, John J.; LeMarchand, Chloe; Finn, Lauren E.; Kim, Moon; Raman, Kiran V.; Komatsu, Kenneth K.; Spiker, Bryce L.; Burkholder, Cole P.; Lang, Sean M.; Soslow, Jonathan H.
Source
The Lancet Child & Adolescent Health; May 2022, Vol. 6 Issue: 5 p303-312, 10p
Subject
Language
ISSN
23524642; 23524650
Abstract
Multisystem inflammatory syndrome in children (MIS-C) is a hyperinflammatory condition associated with antecedent SARS-CoV-2 infection. In the USA, reporting of MIS-C after vaccination is required under COVID-19 vaccine emergency use authorisations. We aimed to investigate reports of individuals aged 12–20 years with MIS-C after COVID-19 vaccination reported to passive surveillance systems or through clinician outreach to the US Centers for Disease Control and Prevention (CDC).